病态肥胖是全关节置换术后假体周围感染行清创、抗生素及假体保留术感染复发的危险因素
该回顾性多中心匹配队列研究比较了病态肥胖(BMI≥40 kg/m²)与非肥胖(BMI<30 kg/m²)患者行清创、抗生素及假体保留术(DAIR)后的感染控制率,发现病态肥胖组治疗失败率57.9%高于非肥胖组36.8%(P=0.035),病态肥胖与重性抑郁障碍/广泛性焦虑障碍诊断均显著增加失败风险(HR分别为1.82和2.09),但症状出现48小时内行DAIR的病态肥胖患者未见再感染风险增加。
要点
- 病态肥胖组DAIR治疗失败率57.9%,高于非肥胖组的36.8%(P=0.035)。
- 病态肥胖与重性抑郁障碍/广泛性焦虑障碍诊断分别使DAIR失败风险增加(HR 1.82和2.09)。
- 症状出现48小时内行DAIR的病态肥胖患者再感染风险未高于非肥胖患者。
核心结论
- 研究结果提示病态肥胖患者DAIR失败风险增加,但若在症状出现48小时内接受DAIR,该风险可被减轻。
研究设计与样本
- 回顾性分析了4家机构的所有DAIR手术结果。
- 将BMI≥40 kg/m²的病态肥胖患者按年龄、性别、手术日期及培养中是否存在葡萄球菌属物种以2:1匹配至BMI<30 kg/m²的非肥胖患者队列。
- 构建Kaplan-Meier生存曲线并行多变量Cox回归分析。
主要发现
- 病态肥胖组治疗失败率为57.9%,非肥胖组为36.8%(P=0.035)。
- 病态肥胖与重性抑郁障碍/广泛性焦虑障碍诊断显著增加失败风险,风险比分别为1.82和2.09。
- 症状出现48小时内接受DAIR的病态肥胖患者与非肥胖患者相比,再感染风险未增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although morbid obesity is an established risk factor for periprosthetic joint infection following total hip arthroplasty and total knee arthroplasty, little is known regarding the infection control rate of this cohort following debridement, antibiotics, and implant retention (DAIR). The purpose of this study is to investigate the infection control rate following DAIR in a morbidly obese patient cohort compared to a nonobese patient cohort and discern the relationship between time from diagnosis to treatment and risk of DAIR failure. METHODS: Results of all DAIR procedures were retrospectively reviewed across 4 institutions. Those with a body mass index of at least 40 kg/m2 were matched 2:1 on the basis of patient age, sex, date of surgery, and presence of staphylococcal species in culture to a cohort of patients with body mass index of <30 kg/m2. Demographic variables were collected for each patient. Kaplan-Meier survivorship curves were constructed and multivariable Cox regression was performed for analysis. RESULTS: The morbidly obese group experienced a higher treatment failure rate (57.9%) compared to the nonobese group (36.8%; P = .035). Morbid obesity and major depressive disorder/generalized anxiety disorder diagnosis significantly increased the risk of failure, with hazard ratios of 1.82 and 2.09, respectively. Morbidly obese patients who received DAIR within 48 hours of symptom presentation did not face an increased risk of reinfection compared to nonobese patients. CONCLUSION: Our findings suggest morbidly obese patients face an increased risk of DAIR failure; however, this risk can be mitigated if DAIR is received within 48 hours of symptom onset.
引用
- Katakam A, Melnic CM, Bedair HS, et al. Morbid Obesity Is a Risk Factor for Infection Recurrence Following Debridement, Antibiotics, and Implant Retention for Periprosthetic Joint Infection. J Arthroplasty. 2020. PMID: 32732000. doi:10.1016/j.arth.2020.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。